BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20441530)

  • 1. Survival following resection of pancreatic endocrine tumors: importance of R-status and the WHO and TNM classification systems.
    Pomianowska E; Gladhaug IP; Grzyb K; Røsok BI; Edwin B; Bergestuen DS; Mathisen O
    Scand J Gastroenterol; 2010 Aug; 45(7-8):971-9. PubMed ID: 20441530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The outcomes after surgical resection in pancreatic endocrine tumors: an institutional experience.
    You DD; Lee HG; Paik KY; Heo JS; Choi SH; Choi DW
    Eur J Surg Oncol; 2009 Jul; 35(7):728-33. PubMed ID: 19188040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcome and long-term survival in 118 consecutive patients with neuroendocrine tumours of the pancreas.
    Fischer L; Kleeff J; Esposito I; Hinz U; Zimmermann A; Friess H; Büchler MW
    Br J Surg; 2008 May; 95(5):627-35. PubMed ID: 18306152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
    Yang M; Tian BL; Zhang Y; Su AP; Yue PJ; Xu S; Wang L
    Pancreas; 2014 Oct; 43(7):1003-8. PubMed ID: 24945681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
    Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
    Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of surgical treatment in ampullary and pancreatic carcinoma and its prognostic parameters after R0-resection].
    Ridwelski K; Meyer F; Schmidt U; Lippert H
    Zentralbl Chir; 2005 Aug; 130(4):353-61. PubMed ID: 16103961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended surgery for advanced pancreatic endocrine tumours.
    Kleine M; Schrem H; Vondran FW; Krech T; Klempnauer J; Bektas H
    Br J Surg; 2012 Jan; 99(1):88-94. PubMed ID: 22135173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
    Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
    Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
    Kazanjian KK; Reber HA; Hines OJ
    Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas.
    Bahra M; Jacob D; Pascher A; Plockinger U; Kristiansen G; Neuhaus P; Langrehr JM
    J Gastroenterol Hepatol; 2007 Jun; 22(6):930-5. PubMed ID: 17489964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use.
    Rau BM; Moritz K; Schuschan S; Alsfasser G; Prall F; Klar E
    Surgery; 2012 Sep; 152(3 Suppl 1):S103-11. PubMed ID: 22766366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Margin status and long-term prognosis of primary pancreatic neuroendocrine tumor after curative resection: Results from the US Neuroendocrine Tumor Study Group.
    Zhang XF; Wu Z; Cloyd J; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha F; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Smith PM; Cho C; Beems M; Schmidt CR; Dillhoff M; Maithel SK; Pawlik TM
    Surgery; 2019 Mar; 165(3):548-556. PubMed ID: 30278986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors and long-term outcome of pancreatic neuroendocrine neoplasms: Ki-67 index shows a greater impact on survival than disease stage. The large experience of the Spanish National Tumor Registry (RGETNE).
    Martin-Perez E; Capdevila J; Castellano D; Jimenez-Fonseca P; Salazar R; Beguiristain-Gomez A; Alonso-Orduña V; Martinez Del Prado P; Villabona-Artero C; Diaz-Perez JA; Monleon A; Marazuela M; Pachon V; Sastre-Valera J; Sevilla I; Castaño A; Garcia-Carbonero R
    Neuroendocrinology; 2013; 98(2):156-68. PubMed ID: 23988576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
    Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
    J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver resection (and associated extrahepatic resections) for metastatic well-differentiated endocrine tumors: a 15-year single center prospective study.
    Elias D; Lasser P; Ducreux M; Duvillard P; Ouellet JF; Dromain C; Schlumberger M; Pocard M; Boige V; Miquel C; Baudin E
    Surgery; 2003 Apr; 133(4):375-82. PubMed ID: 12717354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of the pancreatic adenocarcinoma staging system to pancreatic neuroendocrine tumors.
    Bilimoria KY; Bentrem DJ; Merkow RP; Tomlinson JS; Stewart AK; Ko CY; Talamonti MS
    J Am Coll Surg; 2007 Oct; 205(4):558-63. PubMed ID: 17903729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic neuroendocrine tumors: the impact of surgical resection on survival.
    Hill JS; McPhee JT; McDade TP; Zhou Z; Sullivan ME; Whalen GF; Tseng JF
    Cancer; 2009 Feb; 115(4):741-51. PubMed ID: 19130464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors and survival in endocrine tumor patients: comparison between gastrointestinal and pancreatic localization.
    Panzuto F; Nasoni S; Falconi M; Corleto VD; Capurso G; Cassetta S; Di Fonzo M; Tornatore V; Milione M; Angeletti S; Cattaruzza MS; Ziparo V; Bordi C; Pederzoli P; Delle Fave G
    Endocr Relat Cancer; 2005 Dec; 12(4):1083-92. PubMed ID: 16322345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic score predicting survival after resection of pancreatic neuroendocrine tumors: analysis of 3851 patients.
    Bilimoria KY; Talamonti MS; Tomlinson JS; Stewart AK; Winchester DP; Ko CY; Bentrem DJ
    Ann Surg; 2008 Mar; 247(3):490-500. PubMed ID: 18376195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.